» Articles » PMID: 30111845

Simultaneous B and T Cell Acute Lymphoblastic Leukemias in Zebrafish Driven by Transgenic MYC: Implications for Oncogenesis and Lymphopoiesis

Abstract

Precursor-B cell acute lymphoblastic leukemia (pre-B ALL) is the most common pediatric cancer, but there are no useful zebrafish pre-B ALL models. We describe the first highly- penetrant zebrafish pre-B ALL, driven by human MYC. Leukemias express B lymphoblast-specific genes and are distinct from T cell ALL (T-ALL)-which these fish also develop. Zebrafish pre-B ALL shares in vivo features and expression profiles with human pre-B ALL, and these profiles differ from zebrafish T-ALL or normal B and T cells. These animals also exhibit aberrant lymphocyte development. As the only robust zebrafish pre-B ALL model and only example where T-ALL also develops, this model can reveal differences between MYC-driven pre-B vs. T-ALL and be exploited to discover novel pre-B ALL therapies.

Citing Articles

Diverse Epithelial Lymphocytes in Zebrafish Revealed Using a Novel Scale Biopsy Method.

Park G, Foster C, Malone-Perez M, Hasan A, Macias J, Frazer J J Immunol. 2024; 213(12):1902-1914.

PMID: 39503619 PMC: 11626784. DOI: 10.4049/jimmunol.2300818.


Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining.

Al-Hamaly M, Chernyavskaya Y, Blackburn J J Vis Exp. 2024; (209).

PMID: 39141548 PMC: 11806935. DOI: 10.3791/67059.


Dynamic Changes in Lymphocyte Populations Establish Zebrafish as a Thymic Involution Model.

Hasan A, Macias J, Wood B, Malone-Perez M, Park G, Foster C J Immunol. 2024; 212(11):1733-1743.

PMID: 38656392 PMC: 11163880. DOI: 10.4049/jimmunol.2300495.


Zebrafish-A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers.

Roy D, Subramaniam B, Chong W, Bornhorst M, Packer R, Nazarian J Cancers (Basel). 2024; 16(7).

PMID: 38611039 PMC: 11010887. DOI: 10.3390/cancers16071361.


Learning from Zebrafish Hematopoiesis.

Wu M, Xu J, Zhang Y, Wen Z Adv Exp Med Biol. 2024; 1442:137-157.

PMID: 38228963 DOI: 10.1007/978-981-99-7471-9_9.